483
Hubei Yitai Pharmaceutical Co., LtdFDA 483 - Hubei Yitai Pharmaceutical Co., Ltd - December 13, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Hubei Viti Pharmaceutical Co., Ltd, an API manufacturer in Tianmen, Hubei Province, China, was cited for significant deficiencies in its quality control systems. The inspection revealed a repeat failure to implement an adequate stability testing program for its API drug products and issues with laboratory controls. Specifically, the firm lacked suitable and verified analytical test methods for both finished products and critical raw materials.
Open in Dashboard
ID · d468981e-d7a9-43e7-ac4d-ee85b077f129